Work from our laboratory demonstrates that P450 monooxygenases metabolize arachidonic acid (AA) to epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids (HETEs). These eicosanoids possess potent biological activities including effects on vascular and airway smooth muscle tone, peptide hormone release, and fluid/electrolyte transport. Current research involves: (1) characterization of the CYP2J subfamily P450s at the biochemical and molecular levels; (2) studies on the regulation of CYP2J gene expression; (3) evaluation of the functional roles that CYP2J products play in cell and organ physiology; and (4) examination of this enzyme pathway in animal models of human disease (including ischemic heart disease, diabetes, and hypertension). We have cloned the mouse Cyp2j5 gene, expressed the corresponding cDNA in Sf9 insect cells and shown that the recombinant enzyme catalyzes the biosynthesis of EETs and mid-chain HETEs. Unlike human CYP2J2, mouse CYP2J5 has a relatively narrow tissue distribution and appears to be one of the major renal P450s. Within the kidney, CYP2J5 is highly localized to proximal tubules and collecting ducts, sites of the nephron where EETs and HETEs have been shown to modulate salt and water transport, and mediate the effects of angiotensin II and arginine vasopressin. Alterations in dietary salt intake do not alter renal CYP2J5 expression; however, CYP2J5 is developmentally regulated in the kidney. Maximal CYP2J5 levels occur during a critical period of postnatal renal development when the pressure-natuiresis relationship is established and when renal functional abnormalities are first demonstrable in animals who subsequently develop hypertension. CYP2J-specific antibodies immunoreact with a 55kDa kidney protein that is expressed at much higher levels in spontaneously hypertensive rats than in normotensive controls. These findings suggest a possible role for CYP2J gene products in the development and/or maintenance of the hypertensive phenotype in rodents. Efforts are currently underway to construct mice in which the Cyp2j5 gene has been disrupted in order to study the functional significance of this P450 in kidney development, renal physiology, and in the pathophysiology of hypertension.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES025034-04
Application #
6106634
Study Section
Special Emphasis Panel (LPP)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Lafite, Pierre; André, François; Graves, Joan P et al. (2018) Role of Arginine 117 in Substrate Recognition by Human Cytochrome P450 2J2. Int J Mol Sci 19:
Edin, Matthew L; Hamedani, Behin Gholipour; Gruzdev, Artiom et al. (2018) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia. J Biol Chem 293:3281-3292
Hagar, Jon A; Edin, Matthew L; Lih, Fred B et al. (2017) Lipopolysaccharide Potentiates Insulin-Driven Hypoglycemic Shock. J Immunol 199:3634-3643
Graves, Joan P; Gruzdev, Artiom; Bradbury, J Alyce et al. (2017) Characterization of the Tissue Distribution of the Mouse Cyp2c Subfamily by Quantitative PCR Analysis. Drug Metab Dispos 45:807-816
Hasegawa, Eiichi; Inafuku, Saori; Mulki, Lama et al. (2017) Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization. Proc Natl Acad Sci U S A 114:E7545-E7553
Garcia, Victor; Gilani, Ankit; Shkolnik, Brian et al. (2017) 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension. Circ Res 120:1776-1788
Hanif, Ahmad; Edin, Matthew L; Zeldin, Darryl C et al. (2017) Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A2A receptor and plasma oxylipins. Prostaglandins Other Lipid Mediat 131:83-95
Hoopes, Samantha L; Gruzdev, Artiom; Edin, Matthew L et al. (2017) Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice. PLoS One 12:e0175348
Bettaieb, Ahmed; Koike, Shinichiro; Hsu, Ming-Fo et al. (2017) Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia. Biochim Biophys Acta Gen Subj 1861:2758-2765
Bettaieb, Ahmed; Koike, Shinichiro; Chahed, Samah et al. (2017) Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. FEBS J 284:1970-1986

Showing the most recent 10 out of 138 publications